Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines.
Institute for Dementia Care Asia, Quezon City, Philippines.
Front Public Health. 2021 May 14;9:628700. doi: 10.3389/fpubh.2021.628700. eCollection 2021.
In the midst of competing priorities and limited resources in low-middle-income countries (LMIC), convincing epidemiological evidence is critical for urging governments to develop national dementia plans. The majority of primary epidemiological studies on dementia are from high income countries (HIC). Implications for developing countries are typically extrapolated from these outcomes through modeling, meta-analyses, and systematic reviews. In this study, we directly assessed the incidence of dementia, disability adjusted life years (DALYs), and cost of care among community-dwelling Filipino elderly. This was a follow-up study of the prospective cohort Marikina Memory Ageing Project (MMAP). Baseline assessment was performed in 2011-2012, and follow-up was done in 2015-2016 ( = 748 at follow-up). Incident dementia was determined. Disease burden was computed using the incidence rates and DALYs. Both indirect and direct (medical and non-medical) costs of dementia care were computed. The crude incidence rate was 16 (CI: 13-20) cases per 1,000 person-years (pyr) with 17 (CI: 12-21) per 1,000 pyr for females and 14 (CI: 9-21) per 1,000 pyr for males. Based on this incidence, we project an estimation of 220,632 new cases in 2030, 295,066 in 2040, and 378,461 in 2050. Disease burden was at 2,876 DALYsper 100,000 persons. The economic burden per patient was around Php 196,000 annually (i.e., ~4,070 USD, or 36.7% of average family annual income in the Philippines). The majority (86.29%) of this care expense was indirect cost attributed to estimated lost potential earning of unpaid family caregivers whereas direct medical cost accounted for only 13.48%. We provide the first Filipino community-based data on the incidence of dementia, DALYs, and cost of care to reflect the epidemiologic and economic impact of disease. The findings of this study serve to guide the development of a national dementia plan.
在中低收入国家(LMIC),资源有限,各种优先事项相互竞争,因此有必要提供令人信服的流行病学证据,以敦促政府制定国家痴呆症计划。大多数关于痴呆症的主要流行病学研究都来自高收入国家(HIC)。通过建模、荟萃分析和系统评价,通常可以从这些结果推断出对发展中国家的影响。在这项研究中,我们直接评估了菲律宾社区居住的老年人的痴呆症发病率、残疾调整生命年(DALYs)和护理费用。这是前瞻性队列马林基记忆老化项目(MMAP)的后续研究。基线评估于 2011-2012 年进行,随访于 2015-2016 年进行(随访时为 748 人)。确定了新发痴呆症病例。使用发病率和 DALYs 计算疾病负担。计算了痴呆症护理的间接和直接(医疗和非医疗)成本。未经调整的发病率为 16(95%CI:13-20)例/1000 人年(pyr),女性为 17(95%CI:12-21)例/1000 pyr,男性为 14(95%CI:9-21)例/1000 pyr。根据这一发病率,我们预计 2030 年将有 220,632 例新发病例,2040 年将有 295,066 例,2050 年将有 378,461 例。每 10 万人中有 2,876 个残疾调整生命年(DALYs)。每位患者的经济负担约为每年 196,000 菲律宾比索(即 4,070 美元,占菲律宾家庭年均收入的 36.7%)。其中大部分(86.29%)是由未付家庭护理人员估计的潜在收入损失引起的间接费用,而直接医疗费用仅占 13.48%。我们提供了菲律宾社区痴呆症发病率、DALYs 和护理费用的第一项数据,以反映疾病的流行病学和经济影响。这项研究的结果为制定国家痴呆症计划提供了指导。